BioLife Solutions, Inc. - Common Stock (BLFS)
Competitors to BioLife Solutions, Inc. - Common Stock (BLFS)
Cell and Gene Therapy Catapult
The Cell and Gene Therapy Catapult is a UK-based initiative that competes indirectly by focusing on the development of cell and gene therapy technologies, which requires effective biopreservation solutions. They provide support for companies developing therapies, which may include operational and logistical challenges where BioLife Solutions’ products can be utilized. However, their focus on innovation and developing technologies gives them a customer-centric approach that can effectively draw clients looking for support in therapy development.
Chart Industries, Inc.
Chart Industries competes with BioLife Solutions by offering advanced cryogenic storage solutions and systems for the life sciences and medical industries. They have a strong portfolio in gas management and storage technologies that are crucial for preserving biological materials. While both companies focus on the biobanking and life sciences markets, Chart's extensive history and larger market presence in cryogenics give it an edge in scalability and diversification.
Cryoport, Inc. CYRX +1.77%
Cryoport specializes in temperature-controlled logistics and cryogenic shipping solutions for the biopharmaceutical industry, making it a key competitor to BioLife Solutions in biopreservation and supply chain logistics. They focus on providing end-to-end shipping solutions which can be appealing to customers looking for comprehensive services. While Cryoport excels in logistics, BioLife Solutions offers specialized biopreservation solutions, creating a dynamic of competition based on their differing focuses.
MilliporeSigma
MilliporeSigma, a division of Merck KGaA, competes with BioLife Solutions by providing a broad range of technologies and products for the biomedical and life sciences, including solutions for biopreservation and cell and gene therapy. Their extensive research and development capabilities, combined with integration into Merck's global sales platforms, allow them to maintain a significant competitive advantage in terms of resources and innovation.
Thermo Fisher Scientific Inc. TMO +2.05%
Thermo Fisher Scientific is a significant player in the life sciences market, competing with BioLife Solutions through its wide range of laboratory equipment and biopreservation products. Their extensive distribution network and comprehensive catalog of products allow them to offer a consolidated solution, attracting larger clients in need of integrated services. Overall, Thermo Fisher has a strong competitive advantage due to its size, product diversity, and established market reputation.